Induces hepatic inflammation, lipid deposition, and immune dysregulation; accelerates NAFLD to HCC via NLRP3 inflammasome and bile acid dysregulation. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.